This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, P M
Right arrow Articles by Weinstein, I B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, P M
Right arrow Articles by Weinstein, I B

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 September; 10(9): 4650-4657

Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression.

P M Choi, K M Tchou-Wong and I B Weinstein

Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York 10032.

ABSTRACT

By using a retrovirus-derived vector system, we generated derivatives of the human colon cancer cell line HT29 that stably overexpress a full-length cDNA encoding the beta 1 isoform of rat protein kinase C (PKC). Two of these cell lines, PKC6 and PKC7, displayed an 11- to 15-fold increase in PKC activity when compared with the C1 control cell line that carries the vector lacking the PKC cDNA insert. Both of the overexpresser cell lines exhibited striking alterations in morphology when exposed to the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA). Following exposure to TPA, PKC6 and PKC7 cells displayed increased doubling time, decreased saturation density, and loss of anchorage-independent growth in soft agar; but these effects were not seen with the C1 cells. Also, in contrast to the control cells, the PKC-overproducing cells failed to display evidence of differentiation, as measured by alkaline phosphatase activity, when exposed to sodium butyrate. In addition, the PKC-overexpresser cells displayed decreased tumorigenicity in nude mice, even in the absence of treatment with TPA. These results provide the first direct evidence that PKC can inhibit tumor cell growth. Thus, in some tumors, PKC might act as a growth-suppressor gene.


Mol Cell Biol. 1990 September; 10(9): 4650-4657




This article has been cited by other articles:

  • YOSHIDA, M., MATSUI, Y., IIZUKA, A., IKARASHI, Y. (2009). G2-Phase Arrest Through p21(WAF1 / Cip1) Induction and cdc2 Repression by Gnidimacrin in Human Hepatoma HLE Cells. Anticancer Res 29: 1349-1354 [Abstract] [Full Text]  
  • Park, K. A., Byun, H. S., Won, M., Yang, K.-J., Shin, S., Piao, L., Kim, J. M., Yoon, W.-H., Junn, E., Park, J., Seok, J. H., Hur, G. M. (2007). Sustained activation of protein kinase C downregulates nuclear factor-{kappa}B signaling by dissociation of IKK-{gamma} and Hsp90 complex in human colonic epithelial cells. Carcinogenesis 28: 71-80 [Abstract] [Full Text]  
  • Li, H., Weinstein, I. B. (2006). Protein Kinase C {beta} Enhances Growth and Expression of Cyclin D1 in Human Breast Cancer Cells. Cancer Res. 66: 11399-11408 [Abstract] [Full Text]  
  • Bamberger, A.-M., Briese, J., Gotze, J., Erdmann, I., Schulte, H. M., Wagener, C., Nollau, P. (2006). Stimulation of CEACAM1 expression by 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophore A23187 in endometrial carcinoma cells. Carcinogenesis 27: 483-490 [Abstract] [Full Text]  
  • Pan, Q., Bao, L. W., Kleer, C. G., Sabel, M. S., Griffith, K. A., Teknos, T. N., Merajver, S. D. (2005). Protein Kinase C{varepsilon} Is a Predictive Biomarker of Aggressive Breast Cancer and a Validated Target for RNA Interference Anticancer Therapy. Cancer Res. 65: 8366-8371 [Abstract] [Full Text]  
  • Jiang, X.-H., Tu, S.-P., Cui, J.-T., Lin, M. C. M., Xia, H. H. X., Wong, W. M., Chan, A. O.-O., Yuen, M. F., Jiang, S.-H., Lam, S.-K., Kung, H.-F., Soh, J. W., Weinstein, I. B., Wong, B. C.-Y. (2004). Antisense Targeting Protein Kinase C {alpha} and {beta}1 Inhibits Gastric Carcinogenesis. Cancer Res. 64: 5787-5794 [Abstract] [Full Text]  
  • Park, H.-Y., Wu, H., Killoran, C. E., Gilchrest, B. A. (2004). The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-{beta} on melanosomes. J. Cell Sci. 117: 3659-3668 [Abstract] [Full Text]  
  • Zhao, X., Murata, T., Ohno, S., Day, N., Song, J., Nomura, N., Nakahara, T., Yokoyama, K. K. (2001). Protein Kinase Calpha Plays a Critical Role in Mannosylerythritol Lipid-induced Differentiation of Melanoma B16 Cells. J. Biol. Chem. 276: 39903-39910 [Abstract] [Full Text]  
  • Kermorgant, S., Dessirier, V., Lewin, M. J. M., Lehy, T. (2001). HGF upregulates and modifies subcellular distribution of proteins in colon cancer cell enterocytic differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1068-G1080 [Abstract] [Full Text]  
  • Zonder, J. A., Shields, A. F., Zalupski, M., Chaplen, R., Heilbrun, L. K., Arlauskas, P., Philip, P. A. (2001). A Phase II Trial of Bryostatin 1 in the Treatment of Metastatic Colorectal Cancer. Clin. Cancer Res. 7: 38-42 [Abstract] [Full Text]  
  • Frey, M. R., Clark, J. A., Leontieva, O., Uronis, J. M., Black, A. R., Black, J. D. (2000). Protein Kinase C Signaling Mediates a Program of Cell Cycle Withdrawal in the Intestinal Epithelium. JCB 151: 763-778 [Abstract] [Full Text]  
  • Tseng, C.-P., Ely, B. D., Pong, R.-C., Wang, Z., Zhou, J., Hsieh, J.-T. (1999). The Role of DOC-2/DAB2 Protein Phosphorylation in the Inhibition of AP-1 Activity. AN UNDERLYING MECHANISM OF ITS TUMOR-SUPPRESSIVE FUNCTION IN PROSTATE CANCER. J. Biol. Chem. 274: 31981-31986 [Abstract] [Full Text]  
  • Buse, P., Tran, S. H., Luther, E., Phu, P. T., Aponte, G. W., Firestone, G. L. (1999). Cell Cycle and Hormonal Control of Nuclear-Cytoplasmic Localization of the Serum- and Glucocorticoid-inducible Protein Kinase, Sgk, in Mammary Tumor Cells. A NOVEL CONVERGENCE POINT OF ANTI-PROLIFERATIVE AND PROLIFERATIVE CELL SIGNALING PATHWAYS. J. Biol. Chem. 274: 7253-7263 [Abstract] [Full Text]  
  • Batlle, E., Verdu, J., Dominguez, D., Llosas, M. d. M., Diaz, V., Loukili, N., Paciucci, R., Alameda, F., de Herreros, A. G. (1998). Protein Kinase C-alpha Activity Inversely Modulates Invasion and Growth of Intestinal Cells. J. Biol. Chem. 273: 15091-15098 [Abstract] [Full Text]  
  • Frey, M. R., Saxon, M. L., Zhao, X., Rollins, A., Evans, S. S., Black, J. D. (1997). Protein Kinase C Isozyme-mediated Cell Cycle Arrest Involves Induction of p21waf1/cip1 and p27kip1 and Hypophosphorylation of the Retinoblastoma Protein in Intestinal Epithelial Cells. J. Biol. Chem. 272: 9424-9435 [Abstract] [Full Text]  
  • Tchou, W.-W., Rom, W. N., Tchou-Wong, K.-M. (1996). Novel Form of p21WAF1/CIP1/SDI1 Protein in Phorbol Ester-induced G2/M Arrest. J. Biol. Chem. 271: 29556-29560 [Abstract] [Full Text]  
  • Sauma, S., Friedman, E. (1996). Increased Expression of Protein Kinase Cbeta Activates ERK3. J. Biol. Chem. 271: 11422-11426 [Abstract] [Full Text]  
  • Borner, C., Ueffing, M., Jaken, S., Parker, P. J., Weinstein, I. B. (1995). Two Closely Related Isoforms of Protein Kinase C Produce Reciprocal Effects on the Growth of Rat Fibroblasts. J. Biol. Chem. 270: 78-86 [Abstract] [Full Text]  
  • Haller, H., Lindschau, C., Quass, P., Distler, A., Luft, F. C. (1995). Differentiation of Vascular Smooth Muscle Cells and the Regulation of Protein Kinase C-{alpha}. Circ. Res. 76: 21-29 [Abstract] [Full Text]  
  • DeLa Herreros, A., Fabre, M, Batlle, E, Balague, C, Real, F. (1993). The tumor promoter 12-O-tetradecanoylphorbol-13-acetate blocks differentiation of HT-29 human colon cancer cells. J. Cell Sci. 105: 1165-1172 [Abstract]  
  • Clemens, M. J., Trayner, I., Menaya, J. (1992). The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J. Cell Sci. 103: 881-887  
  • Trump, B. F. (1991). Molecular Mechanisms of Genetic Deregulation in Toxicity and Carcinogenesis July 20-25, 1991, The Gant Conference Center, Aspen, Colorado: Program and Abstracts. Toxicol Pathol 19: 625-669